Ligand validation:8QML

CPS: 3-[(3-CHOLAMIDOPROPYL)DIMETHYLAMMONIO]-1-PROPANESULFONATE

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
8QML_CPS_A_403	85%	28%	0.081	0.947	1.49	1.42	3	10	4	0	100%	0.94
8QML_CPS_A_405	61%	48%	0.077	0.921	0.7	1.31	1	4	2	0	69%	1
8QML_CPS_A_407	18%	47%	0.165	0.824	0.74	1.31	-	7	1	0	60%	1.01
8QML_CPS_A_406	4%	57%	0.256	0.691	0.7	0.96	-	-	0	0	60%	1
5FEZ_CPS_A_402	96%	34%	0.057	0.967	1.46	1.15	7	5	4	0	100%	0.957
3IIX_CPS_A_1701	95%	46%	0.058	0.963	1.33	0.76	1	-	4	0	100%	0.957
5FF3_CPS_A_402	94%	30%	0.078	0.979	1.58	1.21	3	6	4	0	100%	0.957
5FEW_CPS_A_402	94%	23%	0.074	0.973	2.03	1.14	7	7	0	0	100%	0.957
5FES_CPS_A_402	94%	22%	0.069	0.967	1.93	1.35	9	10	0	0	100%	0.957
3CIW_CPS_A_1701	93%	45%	0.064	0.96	1.3	0.82	1	1	2	0	100%	0.957

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.